Covaxin Efficacy 77.8% In Lancet Study; 65.2% Against Delta In Early Data

Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against symptomatic COVID-19 in a...

from NDTV News - Topstories https://ift.tt/3D93Luh